Targeting AMP ‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting
AMP
‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-09
DOI
10.1002/1878-0261.12488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity
- (2018) Xuesong Yuan et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma
- (2018) Zuzana Macek Jilkova et al. Oncotarget
- PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
- (2018) Jin Zeng et al. Theranostics
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Lenvatinib as a therapy for unresectable hepatocellular carcinoma
- (2018) Andrea Spallanzani et al. Expert Review of Anticancer Therapy
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
- (2017) Bede van Schaijik et al. JOURNAL OF CLINICAL PATHOLOGY
- Trends in the Mortality of Hepatocellular Carcinoma in the United States
- (2017) Eliza W. Beal et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- Elimination of cancer stem cells and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking inhibition of tumorigenesis and the potential eradication of HIV-1
- (2017) Jahahreeh Finley MEDICAL HYPOTHESES
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
- (2017) Masatoshi Kudo ONCOLOGY
- Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Jiejie Dong et al. PLoS One
- The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation
- (2017) Anaïs Wanet et al. STEM CELLS
- Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
- (2017) Alicia Bort et al. Oncotarget
- Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
- (2017) et al. Cancers
- Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
- (2016) Abin You et al. Journal of Hematology & Oncology
- Inhibition of acquired-resistance hepatocellular carcinoma cell growth by combining sorafenib with phosphoinositide 3-kinase and rat sarcoma inhibitor
- (2016) Chang-Hao Wu et al. JOURNAL OF SURGICAL RESEARCH
- Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
- (2016) O Lindblad et al. ONCOGENE
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma
- (2015) E. A. Kuczynski et al. CANCER RESEARCH
- Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?
- (2015) D. G. Hardie CLINICAL CANCER RESEARCH
- Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain
- (2015) Tracy Seymour et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro
- (2015) Xu Chen et al. TUMOR BIOLOGY
- Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs
- (2014) Noriaki Hashimoto et al. BMC CANCER
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
- (2014) SUNBIN LING et al. Molecular Medicine Reports
- Emerging role of nanog in tumorigenesis and cancer stem cells
- (2013) Luis E. IV Santaliz-Ruiz et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
- (2013) Yanfei Zhang et al. PLoS One
- Cellular reprogramming and hepatocellular carcinoma development
- (2013) Yun-Wen Zheng WORLD JOURNAL OF GASTROENTEROLOGY
- Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
- (2012) Alejandro Vazquez-Martin et al. CELL CYCLE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
- (2011) D Vara et al. CELL DEATH AND DIFFERENTIATION
- Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties
- (2011) Yuanyuan Ma et al. PLoS One
- Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
- (2011) Ji-Won Jung et al. PLoS One
- Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming
- (2011) Toshio Miki et al. Stem Cell Reviews and Reports
- Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
- (2011) Kenneth C. Valkenburg et al. Cancers
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- AMPKα1 regulates the antioxidant status of vascular endothelial cells
- (2009) Sergio L. Colombo et al. BIOCHEMICAL JOURNAL
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
- (2008) S. Ma et al. MOLECULAR CANCER RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation